Cargando…
Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors
Ornithine transcarbamylase deficiency (OTCD) is the most common inborn error of urea synthesis. Complete OTCD can result in hyperammonemic coma in the neonatal period which can rapidly become fatal. Current acute therapy involves dialysis; chronic therapy involves the stimulation of alternate nitrog...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321078/ https://www.ncbi.nlm.nih.gov/pubmed/21850052 http://dx.doi.org/10.1038/gt.2011.111 |
_version_ | 1782228911189393408 |
---|---|
author | Wang, Lili Wang, Huan Morizono, Hiroki Bell, Peter Jones, David Lin, Jianping McMenamin, Deirdre Yu, Hongwei Batshaw, Mark L. Wilson, James M. |
author_facet | Wang, Lili Wang, Huan Morizono, Hiroki Bell, Peter Jones, David Lin, Jianping McMenamin, Deirdre Yu, Hongwei Batshaw, Mark L. Wilson, James M. |
author_sort | Wang, Lili |
collection | PubMed |
description | Ornithine transcarbamylase deficiency (OTCD) is the most common inborn error of urea synthesis. Complete OTCD can result in hyperammonemic coma in the neonatal period which can rapidly become fatal. Current acute therapy involves dialysis; chronic therapy involves the stimulation of alternate nitrogen clearance pathways; and the only curative approach is liver transplantation. AAV vector based gene therapy would add to current treatment options provided the vector delivers high level and stable transgene expression in liver without dose limiting toxicity. In this study, we employed an AAV2/8-based self-complementary (sc) vector expressing the murine OTC gene under a liver-specific thyroxine-binding globulin (TBG) promoter and examined the therapeutic effects in a mouse model of OTCD, the spf (ash) mouse. Seven days after a single intravenous injection of vector, treated mice showed complete normalization of urinary orotic acid, a measure of OTC activity. We further improved vector efficacy by incorporating a Kozak or Kozak-like sequence into mOTC cDNA which increased the OTC activity by 5- or 2-fold and achieved sustained correction of orotic aciduria for up to 7 months. Our results demonstrate that vector optimizations can significantly improve the efficacy of gene therapy. |
format | Online Article Text |
id | pubmed-3321078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-33210782012-10-01 Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors Wang, Lili Wang, Huan Morizono, Hiroki Bell, Peter Jones, David Lin, Jianping McMenamin, Deirdre Yu, Hongwei Batshaw, Mark L. Wilson, James M. Gene Ther Article Ornithine transcarbamylase deficiency (OTCD) is the most common inborn error of urea synthesis. Complete OTCD can result in hyperammonemic coma in the neonatal period which can rapidly become fatal. Current acute therapy involves dialysis; chronic therapy involves the stimulation of alternate nitrogen clearance pathways; and the only curative approach is liver transplantation. AAV vector based gene therapy would add to current treatment options provided the vector delivers high level and stable transgene expression in liver without dose limiting toxicity. In this study, we employed an AAV2/8-based self-complementary (sc) vector expressing the murine OTC gene under a liver-specific thyroxine-binding globulin (TBG) promoter and examined the therapeutic effects in a mouse model of OTCD, the spf (ash) mouse. Seven days after a single intravenous injection of vector, treated mice showed complete normalization of urinary orotic acid, a measure of OTC activity. We further improved vector efficacy by incorporating a Kozak or Kozak-like sequence into mOTC cDNA which increased the OTC activity by 5- or 2-fold and achieved sustained correction of orotic aciduria for up to 7 months. Our results demonstrate that vector optimizations can significantly improve the efficacy of gene therapy. 2011-08-18 2012-04 /pmc/articles/PMC3321078/ /pubmed/21850052 http://dx.doi.org/10.1038/gt.2011.111 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Wang, Lili Wang, Huan Morizono, Hiroki Bell, Peter Jones, David Lin, Jianping McMenamin, Deirdre Yu, Hongwei Batshaw, Mark L. Wilson, James M. Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors |
title | Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors |
title_full | Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors |
title_fullStr | Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors |
title_full_unstemmed | Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors |
title_short | Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors |
title_sort | sustained correction of otc deficiency in spf (ash) mice using optimized self-complementary aav2/8 vectors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321078/ https://www.ncbi.nlm.nih.gov/pubmed/21850052 http://dx.doi.org/10.1038/gt.2011.111 |
work_keys_str_mv | AT wanglili sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT wanghuan sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT morizonohiroki sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT bellpeter sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT jonesdavid sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT linjianping sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT mcmenamindeirdre sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT yuhongwei sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT batshawmarkl sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors AT wilsonjamesm sustainedcorrectionofotcdeficiencyinspfashmiceusingoptimizedselfcomplementaryaav28vectors |